Ignite Creation Date:
2024-05-05 @ 6:35 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00505453
Status:
COMPLETED
Last Update Posted:
2016-11-04
First Post:
2007-07-20
Brief Title:
A Phase III Open-Label Single-Dose Study to Evaluate the Safety and Immunogenicity of Fluviral Vaccine
Sponsor:
Organization:
GlaxoSmithKline